Literature DB >> 19444146

Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009.

.   

Abstract

Since mid-April 2009, CDC, state and local health authorities in the United States, the World Health Organization (WHO), and health ministries in several countries have been responding to an outbreak of influenza caused by a novel influenza A (H1N1) virus. In March and early April 2009, Mexico experienced outbreaks of respiratory illness subsequently confirmed by CDC and Canada to be caused by the novel virus. The influenza strain identified in U.S. patients was genetically similar to viruses isolated from patients in Mexico. Since recognition of the novel influenza A (H1N1) virus in Mexico and the United States, as of May 6, a total of 21 additional countries had reported cases, with a total of 1,882 confirmed cases worldwide. Several WHO member states are conducting ongoing investigations of this worldwide outbreak, and WHO is monitoring and compiling surveillance data and case reports. On April 29, WHO raised the level of pandemic alert from phase 4 to phase 5, indicating that human-to-human spread of the virus had occurred in at least two countries in one WHO region. This report provides an update of the initial investigations and spread of novel influenza A (H1N1) virus worldwide.

Entities:  

Mesh:

Year:  2009        PMID: 19444146

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  85 in total

1.  Epidemiological aspects of pandemic influenza A(H1N1) virus from 2009 to 2011 in Iran.

Authors:  Jila Yavarian; Maryam Naseri; Azadeh Shadab; Nazanin Z Shafiei Jandaghi; Talat Mokhtari Azad
Journal:  Influenza Other Respir Viruses       Date:  2012-04-06       Impact factor: 4.380

2.  Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method.

Authors:  Yasushi Suzuki; Reiko Saito; Isamu Sato; Hassan Zaraket; Makoto Nishikawa; Tsutomu Tamura; Clyde Dapat; Isolde Caperig-Dapat; Tatiana Baranovich; Takako Suzuki; Hiroshi Suzuki
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

3.  Knowledge, attitudes, and behaviors of low-income women considered high priority for receiving the novel influenza A (H1N1) vaccine.

Authors:  Catherine A Boyd; Julie A Gazmararian; Winifred Wilkins Thompson
Journal:  Matern Child Health J       Date:  2013-07

4.  Poor positive accuracy of QuickVue rapid antigen tests during the influenza A (H1N1) 2009 pandemic.

Authors:  Heather L Stevenson; Michael J Loeffelholz
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

5.  Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.

Authors:  Kathryn Edwards; Germaine Hanquet; Steve Black; Emmanuel Mignot; Christopher Jankosky; Tom Shimabukuro; Elizabeth Miller; Hanna Nohynek; Pieter Neels
Journal:  Biologicals       Date:  2019-05-23       Impact factor: 1.856

6.  A porcine model for initial surge mechanical ventilator assessment and evaluation of two limited-function ventilators.

Authors:  Robert P Dickson; David L Hotchkin; Wayne J E Lamm; Carl Hinkson; David J Pierson; Robb W Glenny; Lewis Rubinson
Journal:  Crit Care Med       Date:  2011-03       Impact factor: 7.598

7.  A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.

Authors:  Mariana Baz; Myeisha Paskel; Yumiko Matsuoka; James R Zengel; Xing Cheng; John J Treanor; Hong Jin; Kanta Subbarao
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

Review 8.  Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.

Authors:  Toshihiro Tanaka; Ken Nakajima; Atsuko Murashima; Facundo Garcia-Bournissen; Gideon Koren; Shinya Ito
Journal:  CMAJ       Date:  2009-06-15       Impact factor: 8.262

9.  Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

Authors:  Sharon K Greene; Martin Kulldorff; Edwin M Lewis; Rong Li; Ruihua Yin; Eric S Weintraub; Bruce H Fireman; Tracy A Lieu; James D Nordin; Jason M Glanz; Roger Baxter; Steven J Jacobsen; Karen R Broder; Grace M Lee
Journal:  Am J Epidemiol       Date:  2009-12-04       Impact factor: 4.897

Review 10.  Guidelines on management of human infection with the novel virus influenza A (H1N1)--a report from the Hospital das Clínicas of the University of São Paulo.

Authors:  Ludhmila Abrahao Hajjar; Denise Schout; Filomena Regina Barbosa Gomes Galas; David Everson Uip; Anna Sara Shafferman Levin; Helio Hehl Caiaffa Filho; Pedro Takanori Sakane; Carlos Alberto Suslik; Jose Manoel de Camargo Teixeira; Eloisa Bonfa; Antonio Alci Barone; Milton de Arruda Martins; Marcos Boulos; Jose Otavio Costa Auler
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.